Perkembangan Vaksin COVID-19 Produksi Dalam Negeri
Pengembangan vaksin COVID-19 produksi dalam negeri melalui kerja sama dengan BUMN maupun perusahaan swasta terus berjalan, dan diharapkan dapat diedarkan dan digunakan pada 2022.
| ABX | ||
| 983.700 | ||
| -4.0420 | -0.0041% | |
| BISNIS-27 | ||
| 596.580 | ||
| -1.7100 | -0.0029% | |
| DBX | ||
| 1,995.943 | ||
| -1.4880 | -0.0007% | |
| ECONOMIC30 | ||
| 135.361 | ||
| -0.2790 | -0.0021% | |
| ESGQKEHATI | ||
| 141.182 | ||
| -0.2510 | -0.0018% | |
| ESGSKEHATI | ||
| 141.265 | ||
| -0.2420 | -0.0017% | |
| I-GRADE | ||
| 239.846 | ||
| -0.7790 | -0.0032% | |
| AUDRP | ||
| 10,386.400 | ||
| -50.4000 | -0.4829% | |
| EURRP | ||
| 16,904.100 | ||
| -58.4000 | -0.3443% | |
| JPYRP | ||
| 104.042 | ||
| -0.3200 | -0.3066% | |
| SINRP | ||
| 11,865.900 | ||
| -27.0000 | -0.2270% | |
| USDRP | ||
| 15,523.000 | ||
| -52.0000 | -0.3339% | |
